Print

VRC01LS

Trial Details:

I Ongoing
National Institute of Allergy and Infectious Diseases (NIAID) October 01, 2015
VRCHIVMAB080-00-AB VRC01-LS is the VRC01 mAb modified by site-directed mutagenesis to increase its binding affinity for FcRn.
VRCHIVMAB080-00-AB Passive Immunization
USA 40
NCT02599896
https://clinicaltrials.gov/ct2/show/study/NCT02599896